Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Early Nutrition Intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nutrition
1 trial -
Early auto-mode
Century Therapeutics
Diabetes Mellitus Type 1 Pre-Existing
1 trial -
EchoGo
United Therapeutics Europe Ltd
Coronary Heart Disease
1 trial -
Eefooton oral solution
Hospital Authority, Hong Kong
Chronic Kidney Diseases
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Elmental diet
Hospital Authority, Hong Kong
Gastro-oesophageal Reflux
1 trial -
EmbryoGlue® (laboratory culture medium)
United Therapeutics Europe Ltd
Infertility
1 trial -
Empagliflozin
MEDA Pharma GmbH & Co. KG
Non Alcoholic Fatty Liver Disease
1 trial -
Energy Balance
United Therapeutics Europe Ltd
Inflammation
1 trial -
Entecavir
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Entecavir 0.5 mg
The First People's Hospital of Lianyungang
Hepatitis B
1 trial -
Enteral immunonutrition
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Nasopharyngeal Carcinoma
1 trial -
Envita Stories Methodology in Long-term care Centres for old adults
Gain Therapeutics
Long-term Care Centres for Old Adults Users
1 trial -
Ergocalciferol
United Therapeutics Europe Ltd
Chronic Kidney Disease
1 trial -
Erythromycin 4% topical gel formulation:
BRIGHT MINDS BIOSCIENCES INC.
Inflammation; Skin
1 trial -
Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Depressive Disorder, Major
1 trial -
Escitalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder (MDD)
1 trial -
Escitalopram (Oral antidepressant)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression - Major Depressive Disorder
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Esketamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources